FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1904557 · Received November 22, 2010

Report

Report Number
2024168-2010-02490
Event Type
Injury
Date Received
November 22, 2010
Date of Event
October 18, 2010
Report Date
October 28, 2010
Manufacturer
AV-TEMECULA
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4): DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WAS NO REPORTED PRODUCT DEFICIENCY. ANGINA AND RESTENOSIS ARE KNOWN ADVERSE EVENTS AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE (IFU). ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED VIA A TRIAL, THAT THE INDEX PROCEDURE TOOK PLACE ON (B)(6) 2009. AFTER PREDILATATION OF THE LESIONS, ONE XIENCE V WAS IMPLANTED IN THE MID LEFT ANTERIOR DESCENDING ARTERY (LAD) AND ONE XIENCE V STENT WAS PLACED IN THE DISTAL CIRCUMFLEX (CX). ON (B)(6) 2010, THE PATIENT WENT IN FOR A SCHEDULED APPOINTMENT AND HAD BEEN EXPERIENCING ILL-DEFINED SHARP CHEST PAIN, NON-EXERTIONAL, NOT RADIATING. THE PATIENT WAS REHOSPITALIZED AND UNDERWENT A REPEAT CATHETERIZATION ON (B)(6) 2010, DURING WHICH THE LAD TARGET LESION AND TARGET VESSEL WAS REVASCULARIZED WITH THE PLACEMENT OF A NON-ABBOTT STENT. THE PATIENT WAS DISCHARGED ON (B)(6) 2010. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA 9050861

Patients

Seq Age Sex Outcome Treatment
1 55 YR Hospitalization| R